MedPath

Randomized, an open controlled trial of memantine in moderate Alzheimer's disease already receiving cholinesterase inhibitors.

Not Applicable
Conditions
Alzheimer&#39
s disease
Registration Number
JPRN-UMIN000011222
Lead Sponsor
Fujita Health University School of Medicine, Department of Psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

cardiac failure, epilepsia,creatinine clearance 30>, other serious physical disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mini-Mental State Examination
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath